{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:44:21Z","timestamp":1725583461480},"publisher-location":"Basel","reference-count":54,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034895477"},{"type":"electronic","value":"9783034883931"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000]]},"DOI":"10.1007\/978-3-0348-8393-1_14","type":"book-chapter","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T06:03:24Z","timestamp":1306044204000},"page":"227-237","source":"Crossref","is-referenced-by-count":1,"title":["Delivery systems and adjuvants for vaccination against HIV"],"prefix":"10.1007","author":[{"given":"Velin","family":"Dominique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Kraehenbuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1126\/science.280.5371.1875","volume":"280","author":"NL Letvin","year":"1998","unstructured":"Letvin NL (1998) Progress in the development of an HIV-I vaccine. Science 280: 1875\u201380","journal-title":"Science"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000028017","volume":"66","author":"D Velin","year":"1998","unstructured":"Velin D, Hopkins S, Kraehenbuhl JP (1998) Delivery systems and adjuvants for vaccinationDelivery systems and adjuvants for vaccination against HIV 235 against HIY. Pathobiology 66: 170\u2013175","journal-title":"Pathobiology"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00002030-199001001-00045","volume":"4","author":"J Chin","year":"1990","unstructured":"Chin J (1990) Global estimates of AIDS and HIV infections.AIDS (London)4: S277\u2013S278","journal-title":"AIDS (London)"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/aid.1994.10.1305","volume":"10","author":"G Milman","year":"1994","unstructured":"Milman G, Sharma O (1994) Mechanisms of HIV\/SIV mucosal transmission.AIDS Res Hum Retrovirus 10:1305\u20131309","journal-title":"AIDS Res Hum Retrovirus"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1084\/jem.183.1.215","volume":"183","author":"AI Spira","year":"1996","unstructured":"Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD (1996) Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.J Exp Med183: 215\u2013225","journal-title":"J Exp Med"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm0197-42","volume":"3","author":"M Bomsel","year":"1997","unstructured":"Bomsel M (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier.Nat Med3: 42\u201347","journal-title":"Nat Med"},{"key":"14_CR7","first-page":"760","volume":"4","author":"HM Amerongen","year":"1991","unstructured":"Amerongen HM, Weltzin RA, Farnet CM, Michetti P, Haseltine WA, Neutra MR (1991) Transepithelial transport of HIV-1 by intestinal M-cells: a mechanism for transmission of AIDS.JAcq Immun Defic Synd Hum R4: 760\u2013765","journal-title":"JAcq Immun Defic Synd Hum R"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/JVI.71.5.3498-3506.1997","volume":"71","author":"AL Howell","year":"1997","unstructured":"Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR (1997) Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.J Virol 71:3498\u20133506","journal-title":"J Virol"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1126\/science.271.5247.324","volume":"271","author":"BF Haynes","year":"1996","unstructured":"Haynes BF, Pantaleo G, Fauci AA (1996) Toward and understanding of the corrElates of protective immunity to HIV infection.Science271: 324\u2013328","journal-title":"Science"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","volume":"279","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V et al (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.Science279: 2103\u20132106","journal-title":"Science"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1126\/science.2431484","volume":"234","author":"CM Walker","year":"1986","unstructured":"Walker CM, Moody DJ, Stites DP, Levy JA (1986) CD8+ lymphocytes can control HIV infectionin vitroby suppressing virus replication.Science234: 1563\u20131566","journal-title":"Science"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.283.5403.857","volume":"283","author":"JE Schmitz","year":"1999","unstructured":"Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ et al (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.Science283: 857\u2013860","journal-title":"Science"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm0297-205","volume":"3","author":"P Borrow","year":"1997","unstructured":"Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB ET AL (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.Nat Med3: 205\u2013211","journal-title":"Nat Med"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.Science278: 1447\u20131450","journal-title":"Science"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/30989","volume":"393","author":"JP Ridge","year":"1998","unstructured":"Ridge JP, Di Rosa F, Matzinger P (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.Nature393: 474\u2013478","journal-title":"Nature"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/355728a0","volume":"355","author":"EA Emini","year":"1992","unstructured":"Emini EA, Schleif WA, Nunberg JH, Conley AJ, Eda Y, Tokiyoshi S, Putney SD, Matsushita S, Cobb KE, Jett CM et al (1992) Prevention of HIV-1 infection in chimpanzees by gpl 20 V3 domain-specific monoclonal antibodyNature 355:728\u2013730","journal-title":"Nature"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/5576","volume":"5","author":"T Brown C","year":"1999","unstructured":"T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, Shibata R (1999) Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma.Nat Med5: 211\u2013216","journal-title":"Nat Med"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/5568","volume":"5","author":"R Shibata","year":"1999","unstructured":"Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA (1999) Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1\/SIV chimeric virus infections of macaque monkeys.Nat Med5: 204\u2013210","journal-title":"Nat Med"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1128\/JVI.68.9.6006-6013.1994","volume":"68","author":"DC Bou-Habib","year":"1994","unstructured":"Bou-Habib DC, Roderiquez G, Oravecz T, Berman PW, Lusso P, Norcross MA (1994) Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.J Virol68: 6006\u20136013","journal-title":"J Virol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"10 270","DOI":"10.1128\/JVI.72.12.10270-10274.1998","volume":"72","author":"PW Parren","year":"1998","unstructured":"Parren PW, Wang M, Trkola A, Binley JM, Purtscher M, Katinger H, Moore JP, Burton DR (1998) Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.J Virol72:10 270\u201310 274","journal-title":". J Virol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1126\/science.283.5400.357","volume":"283","author":"RA LaCasse","year":"1999","unstructured":"LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH (1999) Fusion-competent vaccines: broad neutralization of primary isolates of HIV.Science283: 357\u2013362","journal-title":"Science"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/nm1197-1250","volume":"3","author":"S Mazzoli","year":"1997","unstructured":"Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R et al (1997) HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.Nat Med3: 1250\u20131257","journal-title":"Nat Med"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.14.1.275","volume":"14","author":"MR Neutra","year":"1996","unstructured":"Neutra MR, Pringault E, Kraehenbuhl JP (1996) Antigen sampling across epithelial barriers and induction of mucosal immune responsesAnnu Rev Immunol14: 275\u2013300","journal-title":"Annu Rev Immunol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JVI.65.8.4494-4497.1991","volume":"65","author":"JL Munoz","year":"1991","unstructured":"Munoz JL, McCarthy CA, Clark ME, Hall CB (1991) Respiratory syncytial virus infection in C57BL\/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.J Virol65: 4494\u20134497","journal-title":"J Virol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JVI.69.2.1339-1343.1995","volume":"69","author":"MB Mazanec","year":"1995","unstructured":"Mazanec MB, Coudret CL, Fletcher DR (1995) Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.J Virol69: 1339\u20131343","journal-title":"J Virol"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.272.5258.104","volume":"272","author":"JW Burns","year":"1996","unstructured":"Burns JW Siadat-Pajouh M, Krishnaney AA, Breenberg HB (1996) Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.Science272: 104\u2013107","journal-title":"Science"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","volume":"9","author":"M Bomsel","year":"1998","unstructured":"Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, Dupont C, Desgranges C (1998) Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.Immunity9: 277\u2013287","journal-title":"Immunity"},{"key":"14_CR28","first-page":"221","volume":"1","author":"EL Parr","year":"1992","unstructured":"Parr EL, Parr MB (1992) Immunization for secretory immunity in the female reproductive tract.Vaccine Res 1:221\u2013225","journal-title":"Vaccine Res"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0167-5699(98)01397-8","volume":"20","author":"NA Williams","year":"1999","unstructured":"Williams NA, Hirst TR, Nashar TO (1999) Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.Immunol Today20: 95\u2013101","journal-title":"Immunol Today"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.63.9.3279-3286.1995","volume":"63","author":"S Hopkins","year":"1995","unstructured":"Hopkins S, Kraehenbuhl JP, Sch\u00f6del F, Potts A, Peterson D, De Grandi P, Nardelli-Haefliger D (1995) A recombinantS.typhimuriumvaccine induces local immunity by four different routes of immunization.Infect Immunity63: 3279\u20133286","journal-title":"Infect Immunity"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1084\/jem.172.4.1083","volume":"172","author":"AS Aggarwal","year":"1990","unstructured":"Aggarwal AS, Jaffe R, Hone D, Gross M, Sadoff J (1990) OralSalmonella:Malaria circum-sporozoite recombinants induce specific CD8+ cytotoxic T cells.J Exp Med172: 1083\u20131900","journal-title":"J Exp Med"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1089\/aid.1998.14.1625","volume":"14","author":"M Lagranderie","year":"1998","unstructured":"Lagranderie M, Winter N, Balazuc AM, Gicquel B, Gheorghiu M (1998) A cocktail ofMycobacterium bovisBCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes.AIDS Res Hum Retrovirus14: 1625\u20131633","journal-title":"AIDS Res Hum Retrovirus"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1084\/jem.184.5.1879","volume":"184","author":"WS Gallichan","year":"1996","unstructured":"Gallichan WS, Rosenthal KL (1996) Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization.J Exp Med184: 1879\u20131890","journal-title":"J Exp Med"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/0264-410X(95)00100-F","volume":"13","author":"WS Gallichan","year":"1995","unstructured":"Gallichan WS, Rosenthal K (1995) Specific secretory immune responses in the female genital tract following intranasal immunization with recombinant adenovirus expressing glycoprotein B ofHerpes simplexvirus.Vaccine13: 1589\u20131595","journal-title":"Vaccine"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/124.2.148","volume":"124","author":"FH Top","year":"1971","unstructured":"Top FH, Grossman RA, Barelloni PJ, Segal HE, Dudding BA, Russell PK, Buesher BL (1971) Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.J Infect Dis124: 148\u2013154","journal-title":"J Infect Dis"},{"key":"14_CR36","first-page":"233","volume":"109","author":"AR Schwartz","year":"1974","unstructured":"Schwartz AR, Togo Y, Hornick RB (1974) Clinical evaluation of live, oral type 1, 2 and 5 adenovirus vaccines.Amer Rev Respir Dis109: 233\u2013238","journal-title":"Amer Rev Respir Dis"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nm0697-651","volume":"3","author":"MD Lubeck","year":"1997","unstructured":"Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SCS, Chanda PK, Nigida SM et al (1997) Long term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.Nat Med3: 651\u2013658","journal-title":"Nat Med"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1531159","volume":"255","author":"SL Hu","year":"1992","unstructured":"Hu SL, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE (1992) Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.Science255: 456\u2013459","journal-title":"Science"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.72.10.8264-8272.1998","volume":"72","author":"IM Belyakov","year":"1998","unstructured":"Belyakov IM, Wyatt LS, Ahlers JD, Earl P, Pendleton CD, Kelsall BL, Strober W, Moss B, Berzofsky JA (1998) Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.J Virol72: 8264\u20138272","journal-title":"J Virol"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1086\/515288","volume":"177","author":"ML Clements-Mann","year":"1998","unstructured":"Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S et al NIAIDAIDSVaccine Evaluation Group (1998) Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults.J Infect Dis 177:1230\u20131246","journal-title":"J Infect Dis"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0264-410X(98)00211-4","volume":"17","author":"J Welter","year":"1999","unstructured":"Welter J, Taylor J, Tartaglia J, Paoletti E, Stephensen CB (1999) Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection.Vaccine17: 308\u2013318","journal-title":"Vaccine"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/B978-0-12-524730-6.50038-5","volume-title":"Handbook of mucosal immunology","author":"CO Elson","year":"1994","unstructured":"Elson CO, Dertzbaugh MT (1994) Mucosal adjuvants. In:PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds):Handbook of mucosal immunology.Academic Press, San Diego, 391"},{"key":"14_CR43","first-page":"338","volume":"81","author":"JC Bowen","year":"1994","unstructured":"Bowen JC, Nair SK, Reddy R, Rouse BT (1994) Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.Immunology81: 338\u2013342","journal-title":"Immunology"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.183.4125.656","volume":"183","author":"S Heyningen Van","year":"1974","unstructured":"Van Heyningen S (1974) Cholera Toxin: interaction of subunits with ganglioside aGMT.Science183: 656\u2013657","journal-title":"Science"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/S0021-9258(19)41081-8","volume":"250","author":"DM Gill","year":"1975","unstructured":"Gill DM, King CA (1975) The mechanism of the action of cholera toxin in pigeon erythrocyte lysates.J Biol Chem250: 6424\u20136432","journal-title":"J Biol Chem"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJM198909213211206","volume":"321","author":"M Field","year":"1989","unstructured":"Field M, Rao MC, Chang EB (1989) Intestinal electrolyte transport and diarrheal disease.N Engl J Med321: 800\u2013806","journal-title":"N Engl J Med"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1073\/pnas.94.10.5267","volume":"94","author":"S Yamamoto","year":"1997","unstructured":"Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Yamamoto M, Fujihashi K, Van Ginkel FW, Noda M, Takeda Y, McGhee JR (1997) A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.Proc Natl Acad Sci USA94: 5267\u20135272","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.4049\/jimmunol.161.11.5952","volume":"161","author":"K Imaoka","year":"1998","unstructured":"Imaoka K, Miller CJ, Kubota M, McChesney MB, Lohman B, Yamamoto M, Fujihashi K, Someya K, Honda M, McGhee JR et al (1998) Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1ITh2 help for virus-specific immune responses in reproductive tissues.J Immunol161: 5952\u20135958","journal-title":"J Immunol"},{"key":"14_CR49","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","volume":"160","author":"TC VanCott","year":"1998","unstructured":"VanCott TC, Kaminski RW, Mascola JR, Kalyanaraman VS, Wassef NM, Alving CR, Ulrich JT, Lowell GH, Birx DL (1998) HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.J Immunol160: 2000\u20132012","journal-title":"J Immunol"},{"key":"14_CR50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.67.2.921-927.1999","volume":"67","author":"F Oftung","year":"1999","unstructured":"Oftung F, Naess LM, Wetzler LM, Korsvold GE, Aase A, Hoiby EA, Dalseg R, Holst J, Michaelsen TE, Haneberg B (1999) Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.Infect Immunity67: 921\u2013927","journal-title":"Infect Immunity"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nm0597-526","volume":"3","author":"JDO Boyer","year":"1997","unstructured":"Boyer JDO, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV et al (1997) Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.Nat Med3: 526\u2013532","journal-title":"Nat Med"},{"key":"14_CR52","first-page":"90","volume":"11478-11482","author":"EF Fynan","year":"1993","unstructured":"Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robison HL (1993) DNA vaccines: Protective immunization by parenteral, mucosal, and gene-gun inoculations.Proc Natl Acad Sci USA90: 11478\u201311482","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/515613","volume":"178","author":"RR MacGregor","year":"1998","unstructured":"MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB et al (1998) First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.J Infect Dis178: 92\u2013100","journal-title":"J Infect Dis"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.1998.4616","volume":"90","author":"JD Boyer","year":"1999","unstructured":"Boyer JD, Chattergoon MA, Ugen KE, Shah A, Bennett M, Cohen A, Nyland S, Lacy KE, Bagarazzi ML, Higgins TJ et al (1999) Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-basedtrial. Clin Immunol90: 100\u2013107","journal-title":"trial. Clin Immunol"}],"container-title":["Experientia Supplementum","New Approaches to Drug Development"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-8393-1_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T23:34:15Z","timestamp":1712446455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-8393-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"ISBN":["9783034895477","9783034883931"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-8393-1_14","relation":{},"ISSN":["1023-294X"],"issn-type":[{"type":"print","value":"1023-294X"}],"subject":[],"published":{"date-parts":[[2000]]}}}